Volume 153, Issue 5, Pages e2 (November 2017)

Slides:

Advertisements

Similar presentations

Volume 143, Issue 3, Pages e1 (September 2012)

Advertisements

Volume 136, Issue 1, Pages e2 (January 2009)

Volume 148, Issue 2, Pages e5 (February 2015)

The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis Janneke van Grinsven, Sandra van Brunschot Gastroenterology

Hirschsprung's Disease With Impending Abdominal Compartment Syndrome

Volume 150, Issue 2, Pages e8 (February 2016)

Volume 139, Issue 6, Pages e2 (December 2010)

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis Janneke van Grinsven, Sandra van Brunschot Gastroenterology

Volume 148, Issue 2, Pages e5 (February 2015)

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Volume 133, Issue 5, Pages (November 2007)

Effectiveness of Hepatitis B Treatment in Clinical Practice

A Patient With Left Upper Abdominal Pain Who Had Petit Sac

Outcomes Among Living Liver Donors

Volume 149, Issue 2, Pages e3 (August 2015)

Volume 141, Issue 4, Pages (October 2011)

Hirschsprung's Disease With Impending Abdominal Compartment Syndrome

Acute Gastric Outlet Obstruction After Left Hemicolectomy

Volume 139, Issue 5, Pages e1 (November 2010)

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy Christina Reimer, Bo Søndergaard, Linda.

Volume 154, Issue 4, Pages e1 (March 2018)

Unusual Case of an Upset Stomach

Volume 150, Issue 4, Pages (April 2016)

Volume 150, Issue 4, Pages (April 2016)

Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial Andres Acosta, Michael Camilleri,

Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study Henry P. Parkman,

Volume 155, Issue 5, Pages e2 (November 2018)

Abdominal Pain in a Patient 13 Years After Roux-en-Y Gastric Bypass

Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss Jan Tack, Huynh Giao Ly, Florencia Carbone, Hanne Vanheel, Tim Vanuytsel,

A Rare Cause of Postprandial Abdominal Pain and Nausea

Volume 143, Issue 5, Pages e2 (November 2012)

Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis Evan S. Dellon, David A. Katzka, Margaret.

A. Sidney Barritt, Michael W. Fried Gastroenterology

Volume 150, Issue 2, Pages e8 (February 2016)

Volume 141, Issue 1, Pages e1 (July 2011)

Volume 149, Issue 2, Pages e2 (August 2015)

This Month in Gastroenterology

Covering the Cover Gastroenterology

Postprandial Uridine Physiology Is Altered by Obesity

Volume 151, Issue 1, Pages e6 (July 2016)

Efficacy of Linaclotide for Patients With Chronic Constipation

Acute Abdominal Pain in a Teenager With Anorexia Nervosa

Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study Timna Naftali, Lihi Bar-Lev Schleider,

Mark Topazian, Michael Camilleri, Felicity T. Enders, Jonathan E

Chronic Abdominal Pain and Depressive Symptoms: Analysis of the National Longitudinal Study of Adolescent Health Nader N. Youssef, Katherine Atienza,

Volume 148, Issue 4, Pages e2 (April 2015)

Volume 148, Issue 3, Pages e4 (March 2015)

Volume 131, Issue 5, Pages (November 2006)

Gastric Rupture Gastroenterology

Benjamin Kloesel, Vishal S. Chandan, Glenn L. Alexander

Volume 136, Issue 4, Pages (April 2009)

Pathophysiology and treatment of functional dyspepsia

Jikyoung Lee, Jong Jin Hyun, Hong Sik Lee Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

An Elderly Woman With Upper Abdominal Pain and a 60-Pound Weight Loss

Volume 143, Issue 3, Pages e1 (September 2012)

Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo Barjesh Chander Sharma, Praveen.

Volume 137, Issue 2, Pages (August 2009)

Pao-Ying Lin, Horng-Yuan Lou, Chun-Chao Chang Gastroenterology

Would Free Fatty Acids Enhance Treatment of Obesity?

Volume 149, Issue 7, Pages e4 (December 2015)

Unusual Cause of Abdominal Pain After Laparoscopic Cholecystectomy

A Palpable Mass in a Young Man With Chronic Lower Abdominal Pain

Young Chul Kim, Yong Eun Chung, Joon Seok Lim Gastroenterology

Electronic Clinical Challenges and Images in GI

Volume 139, Issue 6, Pages e2 (December 2010)

Controversies in Liver Transplantation for Hepatitis C

A Female Patient With Persistent Epigastric Pain for 1 Week

Unrelenting Abdominal Pain after Recent Initiation of a Direct Oral Anticoagulant: A Cause for Concern Nicholas R. Crews, Nabil Fayad Gastroenterology

Presentation transcript:

Volume 153, Issue 5, Pages 1240-1250.e2 (November 2017) Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study Michael Camilleri, Richard W. McCallum, Jan Tack, Sharon C. Spence, Keith Gottesdiener, Fred T. Fiedorek Gastroenterology Volume 153, Issue 5, Pages 1240-1250.e2 (November 2017) DOI: 10.1053/j.gastro.2017.07.035 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 (A) Experimental design. Sx, symptom; Rx, treatment; QD, once daily; BID, twice daily. (B) CONSORT flow chart. Gastroenterology 2017 153, 1240-1250.e2DOI: (10.1053/j.gastro.2017.07.035) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 (A) Change from baseline through week 12 in DGSSD (4-symptom [nausea, postprandial fullness, abdominal pain, bloating] composite score in total numeric points; full analysis set). (B) Change from baseline through week 12 for each individual symptom. Note that the * and † symbols reflect differences relative to placebo treatment. Gastroenterology 2017 153, 1240-1250.e2DOI: (10.1053/j.gastro.2017.07.035) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 1 Improvements in GCSI-DD at week 12 (p comparisons vs. placebo). Gastroenterology 2017 153, 1240-1250.e2DOI: (10.1053/j.gastro.2017.07.035) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 2 Change from Baseline over 12 Weeks for Global Assessment of Symptoms: “Overall, how would you rate your symptoms in the past 7 days?” Gastroenterology 2017 153, 1240-1250.e2DOI: (10.1053/j.gastro.2017.07.035) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 3 Decrease in gastric emptying T1/2 at end of treatment period compared to baseline in each group. Gastroenterology 2017 153, 1240-1250.e2DOI: (10.1053/j.gastro.2017.07.035) Copyright © 2017 AGA Institute Terms and Conditions